You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage IIIC melanoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma Trial in Salt Lake City (Nivolumab, HF10)

Terminated
Has Results
  • Melanoma
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Jun 9, 2022

Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7 Trial in Rochester (drug,

Active, not recruiting
  • Metastatic Melanoma
  • +6 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 13, 2023

Metastatic Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7 Trial in Jacksonville (drug,

Active, not recruiting
  • Metastatic Melanoma
  • +3 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jan 3, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +20 more
  • Neoantigen Peptide Vaccine
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 7, 2022

Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7 Trial in

Active, not recruiting
  • Stage III Cutaneous Melanoma AJCC v7
  • +4 more
  • Cryosurgery
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic
Jan 3, 2023

Recurrent Melanoma, Stage IIIB Skin Melanoma, Stage IIIC Skin Melanoma Trial in Buffalo (Recombinant Human Hsp110-gp100

Terminated
  • Recurrent Melanoma
  • +3 more
  • Recombinant Human Hsp110-gp100 Chaperone Complex Vaccine
  • Laboratory Biomarker Analysis
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2022

Advanced Malignant Solid Tumor, Stage III Cutaneous Melanoma AJCC v7, Stage III Prostate Cancer AJCC v7 Trial in New Brunswick

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +9 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Jan 25, 2023

Clinical Stage III Cutaneous Melanoma AJCC v8, Pathologic Stage III Cutaneous Melanoma AJCC v8, Pathologic Stage IIIA Cutaneous

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +5 more
  • Jacksonville, Florida
  • +2 more
Oct 21, 2022

Metastatic Melanoma Trial in Louisville (Ipilimumab)

Terminated
Has Results
  • Metastatic Melanoma
  • Louisville, Kentucky
    James Graham Brown Cancer Center
Oct 22, 2021

Metastatic Melanoma Trial in Louisville (Ipilimumab, GM-CSF)

Completed
Has Results
  • Metastatic Melanoma
  • Louisville, Kentucky
    James Graham Brown Cancer Center
Oct 22, 2021

Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma

Recruiting
  • Clinical Stage I Cutaneous Melanoma AJCC v8
  • +33 more
  • Informational Intervention
  • +4 more
  • Los Angeles, California
  • +4 more
Dec 14, 2022

Pathologic Stage IIIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Pathologic Stage IIID

Active, not recruiting
  • Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 9, 2022

Metastatic Malignant Tumor in the Brain, Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7 Trial in Houston (drug,

Active, not recruiting
  • Metastatic Malignant Neoplasm in the Brain
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 15, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 Trial

Active, not recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +4 more
  • Dabrafenib Mesylate
  • +3 more
  • Philadelphia, Pennsylvania
    Perelman Center for Advanced Medicine
Dec 29, 2021

Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma

Recruiting
  • Clinical Stage 0 Cutaneous Melanoma AJCC v8
  • +43 more
  • Best Practice
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2022

Toxicity and Symptom Burden in Chronic Cancer Survivors With

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +7 more
  • Assessment
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 6, 2022

Metastatic Melanoma Trial in Netherlands (drug, device, procedure)

Terminated
  • Metastatic Melanoma
  • Vemurafenib plus cobimetinib
  • +3 more
  • Amsterdam, Netherlands
  • +9 more
Nov 24, 2022

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Bladder Carcinoma

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +41 more
  • Ipilimumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 11, 2022

Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7 Trial in

Completed
Has Results
  • Stage III Cutaneous Melanoma AJCC v7
  • +5 more
  • Aldesleukin
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 17, 2022

BRAF V600E Mutation Present, BRAF V600K Mutation Present, Metastatic Malignant Solid Tumor Trial in Boston (Dabrafenib,

Active, not recruiting
  • BRAF V600E Mutation Present
  • +9 more
  • Boston, Massachusetts
  • +1 more
Jun 28, 2022

Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma

Recruiting
  • Clinical Stage 0 Cutaneous Melanoma AJCC v8
  • +21 more
  • Informational Intervention
  • Survey Administration
  • New Brunswick, New Jersey
  • +1 more
Apr 6, 2022

Pharmacogenomics Testing in Directing Optimal Use of Supportive

Recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +45 more
  • Biospecimen Collection
  • +3 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Feb 3, 2022

Melanoma Trial in Norway (BGB324+pembrolizumab, BGB324+dabrafenib and trametinib, pembrolizumab)

Active, not recruiting
  • Melanoma
  • Bergen, Norway
  • +4 more
Aug 24, 2022

Metastatic Melanoma Trial in Darlinghurst, Sydney, Brisbane (Palliative radiotherapy, Dabrafenib and trametinib (combination))

Completed
  • Metastatic Melanoma
  • Palliative radiotherapy
  • Dabrafenib and trametinib (combination)
  • Darlinghurst, New South Wales, Australia
  • +2 more
Apr 6, 2022

Pathologic Stage IIIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Pathologic Stage IIID

Recruiting
  • Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
  • +2 more
  • Ipilimumab
  • +3 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Feb 11, 2022